• Home
  • Latest
  • Fortune 500
  • Finance
  • Tech
  • Leadership
  • Lifestyle
  • Rankings
  • Multimedia
Right Arrow Button IconLeft Arrow Button IconHome
Right Arrow Button IconAlzheimer's

Alzheimer's

Page 5 of 8
Biogen aduhelm aducanumab Alzheimer's doctor disapproval
NewslettersThe never ending Biogen Alzheimer’s drug saga delivers yet another twist
By Sy MukherjeeJuly 8, 2021
Biogen aduhelm aducanumab Alzheimer's doctor disapproval
HealthBiogen makes a drastic move, as doctors refuse to prescribe its controversial Alzheimer’s drug
By Sy MukherjeeJuly 8, 2021
The exterior of the headquarters of biotechnology company Biogen in Cambridge, MA is pictured on March 21, 2019.
HealthBiogen won its controversial Alzheimer’s drug approval. Which drugmakers will see the next big win?
By Sy MukherjeeJune 9, 2021
The exterior of the headquarters of biotechnology company Biogen in Cambridge, MA is pictured on March 21, 2019.
HealthFDA approves Biogen’s controversial Alzheimer’s drug in historic decision
By Sy MukherjeeJune 7, 2021
FDA Biogen Alzheimer's Janet Woodcock
HealthPresident Biden still hasn’t appointed a permanent FDA commissioner. That has big implications for upcoming drug approvals
By Sy MukherjeeMay 25, 2021
Alzheimer's drug week
NewslettersA week about Alzheimer’s drug development
By Sy MukherjeeMarch 18, 2021
Biogen Sangamo Alzheimers gene therapy
NewslettersBiogen is doubling down on Alzheimer’s with a massive gene therapy deal
By Sy MukherjeeFebruary 28, 2020
Biogen Alzheimers Drug Data
NewslettersThe Broader Implications of Biogen’s Divisive Alzheimer’s Drug
By Sy MukherjeeDecember 5, 2019
Biogen Stock Alzheimer's Aducanumab
NewslettersBiogen Stock Falls After Analyst Throws Cold Water on Its Alzheimer’s Drug Bet
By Sy MukherjeeDecember 2, 2019
Bill Gates Alzheimers Part the Cloud
NewslettersBill Gates Commits $10 Million More for Alzheimer’s Research to ‘Part the Cloud’
By Sy MukherjeeNovember 4, 2019
Biogen Alzheimers Aducanumab
NewslettersLet’s Talk About Biogen’s Stunning Alzheimer’s Drug Reversal: Brainstorm Health
By Sy MukherjeeOctober 22, 2019
A logo of the Swiss pharmaceuticals gian
HealthRoche Reports Another Failure in Big Pharma’s Search for Alzheimer’s Treatment
By Lucas LaursenJanuary 30, 2019
A New Blood Test Could Detect Alzheimers 10 Years Earlier
HealthA New Blood Test Could Detect Alzheimers 10 Years Earlier
By Emily PriceJanuary 21, 2019
The Power of a Joint Venture
MagazineThe Power of a Joint Venture
By Clifton LeafJanuary 18, 2019
Dr. Paul Cox poses for a portrait at Grand Teton National Park near Jackson Hole, Wyoming on October 24, 2018.
FeaturesCould This Radical New Approach to Alzheimer’s Lead to a Breakthrough?
By Rick TetzeliJanuary 18, 2019
1...
  • 3
  • 4
  • 5
  • 6
  • 7
8
Most Popular
Success
Apple cofounder Ronald Wayne—whose stake would be worth up to $400 billion had he not sold it in 1976—says that at 91, he has no regretsplaceholder alt text
By Preston ForeApril 27, 2026
AI
‘The cost of compute is far beyond the costs of the employees’: Nvidia executive says right now AI is more expensive than paying human workersplaceholder alt text
By Sasha RogelbergApril 28, 2026
Energy
‘Take the money and run’: Johns Hopkins economist Steve Hanke on why the UAE quit OPECplaceholder alt text
By Shawn TullyApril 29, 2026
Fortune Secondary Logo
Rankings
  • 100 Best Companies
  • Fortune 500
  • Global 500
  • Fortune 500 Europe
  • Most Powerful Women
  • World's Most Admired Companies
  • See All Rankings
  • Lists Calendar
Sections
  • Finance
  • Fortune Crypto
  • Features
  • Leadership
  • Health
  • Commentary
  • Success
  • Retail
  • Mpw
  • Tech
  • Lifestyle
  • CEO Initiative
  • Asia
  • Politics
  • Conferences
  • Europe
  • Newsletters
  • Personal Finance
  • Environment
  • Magazine
  • Education
Customer Support
  • Frequently Asked Questions
  • Customer Service Portal
  • Privacy Policy
  • Terms Of Use
  • Single Issues For Purchase
  • International Print
Commercial Services
  • Advertising
  • Fortune Brand Studio
  • Fortune Analytics
  • Fortune Conferences
  • Business Development
  • Group Subscriptions
About Us
  • About Us
  • Press Center
  • Work At Fortune
  • Terms And Conditions
  • Site Map
  • About Us
  • Press Center
  • Work At Fortune
  • Terms And Conditions
  • Site Map
  • Facebook icon
  • Twitter icon
  • LinkedIn icon
  • Instagram icon
  • Pinterest icon

© 2026 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and Privacy Notice | Do Not Sell/Share My Personal Information
FORTUNE is a trademark of Fortune Media IP Limited, registered in the U.S. and other countries. FORTUNE may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.